Skip to main content
SpringerLink
Log in

Therapeutic Neuromodulation for Treatment of Schizophrenia

  • Chapter
  • First Online:
Schizophrenia

  • 4254 Accesses

Abstract

While antipsychotics are the mainstay of treatment for schizophrenia, many patients do not achieve an adequate response. Indeed, a significant percentage are refractory to medication, including the most effective agent available, clozapine. As a result, there is a need for alternative treatments which are both effective and safe. Therapeutic neuromodulation includes such approaches as electroconvulsive therapy, transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain stimulation and represents a growing field of study for refractory symptoms. This chapter discusses the potential role of such device-based therapies in schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shergill SS, Murray RM, McGuire PK. Auditory hallucinations: a review of psychological treatments. Schizophr Res. 1998;32(3):137–50.

    Article  PubMed  CAS  Google Scholar 

  2. Kane JM. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview. Br J Psychiatry. 1992;160(17):41–5.

    Google Scholar 

  3. Cerletti U. Old and new information about electroshock. Am J Psychiatry. 1950;107(2):87–94.

    PubMed  CAS  Google Scholar 

  4. Haskett RF, Loo C. Role of psychotropic medications during ECT in the treatment of depression, mania and schizophrenia. J ECT. 2010;26(3):196–201.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  5. Taylor S. Electroconvulsive therapy: a review of history, patient selection, technique, and medication management. South Med J. 2007;100(5):494–8.

    Article  PubMed  Google Scholar 

  6. Bolwig TG. How does electroconvulsive therapy work? Theories on its mechanism. Can J Psychiatry. 2011;56(1):13–8.

    PubMed  Google Scholar 

  7. Goswani U, Kumar U, Singh B. Efficacy of electroconvulsive therapy in treatment resistant schizophrenia: a double-blind study. Indian J Psychiatry. 2003;45(1):26–9.

    Google Scholar 

  8. Kupchik M, Spivak B, Mester R, et al. Combined electroconvulsive-clozapine therapy. Clin Neuropharmacol. 2000;23:14–6.

    Article  PubMed  CAS  Google Scholar 

  9. Chanpattana W, Somchai Chakrabhand ML. Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome. Psychiatry Res. 2001;105:107–15.

    Article  PubMed  CAS  Google Scholar 

  10. Nothdurfter C, Eser D, Schule C, et al. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 2006;7(3):162–70.

    Article  PubMed  Google Scholar 

  11. Suppes T, Webb A, Carmody T, et al. Is postictal electrical silence a predictor of response to electroconvulsive therapy? J Affect Disord. 1996;41:55–8.

    Article  PubMed  CAS  Google Scholar 

  12. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2005;2:CD000076

    Google Scholar 

  13. Painuly N, Chakrabarti S. Combined use of electroconvulsive therapy and antipsychotics in schizophrenia: the Indian evidence. A review and a meta-analysis. J ECT. 2006;22:59–66.

    Article  PubMed  Google Scholar 

  14. Matheson SL, Green MJ, Loo C, Carr VJ. Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizophrenia: a systematic meta-review. Schizophr Res. 2010;118:201–10.

    Article  PubMed  CAS  Google Scholar 

  15. Gazdag G, Ungvari GS. Non-pharmacological biological therapies in schizophrenia. Neuropsychopharmacol Hung. 2011;13(4):233–8.

    PubMed  Google Scholar 

  16. Zervas IM, Theleritis C, Soldatos CR. Using ECT in schizophrenia: a review from a clinical perspective. World J Biol Psychiatry. 2012;13:96–105.

    Article  PubMed  Google Scholar 

  17. Rosebush PI, Mazurek MF. Catatonia and its treatment. Schizophr Bull. 2009;36(2):239–42.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Makhinson M, Furst BA, Shuff MK, Kwon GE. Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration. J ECT. 2012;28(3):e35–6.

    Article  PubMed  Google Scholar 

  19. Häßler F, Reis O, Weirich S, Hoppner J, Pohl B, Buchmann J. A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy. Z Kinder Jugendpscychiatr Psychother. 2013;41(1):69–74.

    Article  Google Scholar 

  20. Rohland BM, Caroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord. 1993;29(4):255–61.

    Article  PubMed  CAS  Google Scholar 

  21. Escobar R, Rios A, Montoya ID, et al. Clinical and cerebral blood flow changes in catatonic patients treated with ECT. J Psychosom Res. 2000;49:423–9.

    Article  PubMed  CAS  Google Scholar 

  22. Girish K, Gill NS. Electroconvulsive therapy in lorazepam non-responsive catatonia. Indian J Psychiatry. 2003;45(1):21–5.

    PubMed Central  PubMed  CAS  Google Scholar 

  23. Suzuki K, Awata S, Takano T, et al. Improvement of psychiatric symptoms after electroconvulsive therapy in young adults with intractable first-episode schizophrenia and schizophreniform disorder. J Exp Med. 2006;210:213–20.

    Google Scholar 

  24. Baeza I, Flamarique I, Garrido JM, et al. Clinical experience using electroconvulsive therapy in adolescents with schizophrenia spectrum disorders. J Child Adolesc Psychopharmacol. 2010;20(3):205–9.

    Article  PubMed  Google Scholar 

  25. Chanpattana W, Sackeim HA. Electroconvulsive therapy in treatment-resistant schizophrenia. J ECT. 2010;26(4):289–98.

    Article  PubMed  Google Scholar 

  26. Levy-Rueff M, Gourevitch R, Loo H, Olie JP, Amado I. Maintenance electroconvulsive therapy: an alternative treatment for refractory schizophrenia and schizoaffective disorders. Psychiatry Res. 2010;175:280–3.

    Article  PubMed  Google Scholar 

  27. Kristensen D, Bauer J, Hageman I, Jorgensen MB. Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas. Eur Arch Psychiatry Clin Neurosci. 2011;261:425–32.

    Article  PubMed  Google Scholar 

  28. Chanpattana W, Andrade C. ECT for treatment-resistant schizophrenia: a response from the far east to the UK nice report. J ECT. 2006;22:4–12.

    Article  PubMed  Google Scholar 

  29. Lerer B, Shapira B, Calev A, et al. Antidepressant and cognitive effects of twice-versus three-times-weekly ECT. Am J Psychiatry. 1995;152(4):564–70.

    PubMed  CAS  Google Scholar 

  30. Charlson F, Siskind D, Doi SAR, et al. ECT efficacy and treatment course: a systematic review and meta-analysis of twice vs thrice weekly schedules. J Affect Disord. 2012;138:1–8.

    Article  PubMed  Google Scholar 

  31. Chanpattana W, Charabhand MLS, Kitaroonchai W, et al. Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia. J Med Assoc Thai. 1999;82:477–83.

    PubMed  CAS  Google Scholar 

  32. Pompili M, Lester D, Dominici G, et al. Indications for electroconvulsive treatment in schizophrenia: a systematic review. Schizophr Res. 2013;146(1–3):1–9.

    Article  PubMed  Google Scholar 

  33. American Psychiatric Association Committee on Electroconvulsive Therapy. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (A task force report of the American Psychiatric Association). 2nd ed. Washington, DC: American Psychiatric Association; 2001.

    Google Scholar 

  34. Buchannan RW, Kreyenbuhl J, Kelly DL, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull. 2010;36:71–93.

    Article  Google Scholar 

  35. Post A, Keck ME. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanism? J Psychiatr Res. 2001;35:193–215.

    Article  PubMed  CAS  Google Scholar 

  36. Slotema CW, Blom JD, Hoek HW, Sommer IEC. Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry. 2010;71(7):873–84.

    Article  PubMed  Google Scholar 

  37. Jasper HH. The ten-twenty electrode system of the International Federation. Electroencephalogr Clin Neurophysiol. 1958;66:376–82.

    Google Scholar 

  38. Geller V, Grisaru N, Abarbanel JM, Lemberg T, Belmaker RH. Slow magnetic stimulation of prefrontal cortex in depression and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:105–10.

    Article  PubMed  CAS  Google Scholar 

  39. Feinsod M, Kreinin B, Chistyakov A, Klein E. Preliminary evidence for a beneficial effect of low-frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia. Depress Anxiety. 1998;7:65–8.

    Article  PubMed  CAS  Google Scholar 

  40. Hoffman RE, Boutros NN, Berman RM, et al. Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated “voices”. Biol Psychiatry. 1999;46:130–2.

    Article  PubMed  CAS  Google Scholar 

  41. Hoffman RE, Boutros NN, Hu S, Berman RM, Krystal JH, Charney DS. Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet. 2000;355:1073–5.

    Article  PubMed  CAS  Google Scholar 

  42. Hoffman RE, Hawkins KA, Gueorguieva R, et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry. 2003;60:49–56.

    Article  PubMed  Google Scholar 

  43. Hoffman RE, Gueorguieva R, Hawkins KA, et al. Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry. 2005;58:97–104.

    Article  PubMed  Google Scholar 

  44. Fitgerald PB, Benitez J, Daskalakis JZ, et al. A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. J Clin Psychopharmacol. 2005;25(4):358–62.

    Article  Google Scholar 

  45. Hoffman RE, Wu K, Pittman B, et al. Transcranial magnetic stimulation of Wernicke’s and right homologous sites to curtail “voices”: a randomized trial. Biol Psychiatry. 2013;73:1008–14.

    Article  PubMed  Google Scholar 

  46. McIntosh AM, Semple D, Tasker K, et al. Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Res. 2004;127:9–17.

    Article  PubMed  Google Scholar 

  47. Poulet E, Brunelin J, Bediou B, et al. Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biol Psychiatry. 2005;57:188–91.

    Article  PubMed  Google Scholar 

  48. Chibarro G, Daniele M, Alagona G, et al. Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations. Neurosci Lett. 2005;383:54–7.

    Article  Google Scholar 

  49. Saba G, Verdon CM, Kalalou K, et al. Transcranial magnetic stimulation in the treatment of schizophrenic symptoms: a double blind sham controlled study. J Psychiatr Res. 2006;40:147–52.

    Article  PubMed  CAS  Google Scholar 

  50. Lee SH, Kim W, Chung YC, et al. A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett. 2005;376:177–81.

    Article  PubMed  CAS  Google Scholar 

  51. Jandl M, Steyer J, Weber M, et al. Treating auditory hallucinations by transcranial magnetic stimulation: a randomized controlled cross-over trial. Neuropsychobiology. 2006;53:63–9.

    Article  PubMed  Google Scholar 

  52. Brunelin J, Poulet E, Bediou B, et al. Low frequency repetitive transcranial magnetic stimulation improves source monitoring deficit in hallucinating patients with schizophrenia. Schizophr Res. 2006;81:41–5.

    Article  PubMed  Google Scholar 

  53. Rosa MO, Gattaz WF, Rosa MA, et al. Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine. J Clin Psychiatry. 2007;68(10):1528–32.

    Article  PubMed  CAS  Google Scholar 

  54. Vercammen A, Knegtering H, Bruggeman R, et al. Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trial. Schizophr Res. 2009;114:172–9.

    Article  PubMed  Google Scholar 

  55. Loo CK, Sainsbury K, Mitchell P, Hadzi-Pavlovic D, Sachdev PS. A sham controlled trial of left and right temporal rTMS for the treatment of auditory hallucinations. Psychol Med. 2010;40:541–6.

    Article  PubMed  CAS  Google Scholar 

  56. de Jesus DR, Gil A, Barbosa L, et al. A pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine. Psychiatry Res. 2011;188:203–7.

    Article  PubMed  Google Scholar 

  57. Aleman A, Sommer IE, Khan RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin Psychiatry. 2007;68(3):416–21.

    Article  PubMed  Google Scholar 

  58. Tranulis C, Sepehry AA, Galinowski A, Stip E. Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A meta-analysis. Can J Psychiatry. 2008;53(9):577–86.

    PubMed  Google Scholar 

  59. Frietas C, Fregni F, Pascual-Leone A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation on negative and positive symptoms in schizophrenia. Schizophr Res. 2009;108:11–24.

    Article  Google Scholar 

  60. Slotema CW, Aleman A, Daskalakis ZJ, Sommer IE. Meta-analysis of repetitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month. Schizophr Res. 2012;42:40–5.

    Article  Google Scholar 

  61. Hovington CL, McGirr A, Lepage M, Berlim MT. Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: a systematic review of recent meta-analyses. Ann Med. 2013;45(4):308–21.

    Article  PubMed  Google Scholar 

  62. Jardri R, Bubrovszky M, Demeulemeester M, et al. Repetitive transcranial magnetic stimulation to treat early-onset auditory hallucinations. J Am Acad Child Adolesc Psychiatry. 2012;51(9):947–9.

    Article  PubMed  Google Scholar 

  63. Thirthalli J, Bharadway B, Kulkarni S, Gangadhar BN, Kharawala S, Andrade C. Successful use of maintenance rTMS for 8 months in a patient with antipsychotic-refractory auditory hallucinations. Schizophr Res. 2008;100:351–2.

    Article  PubMed  Google Scholar 

  64. Tang WK, Ungvari GS. Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: a prospective, open trial. J ECT. 2002;18(2):90–4.

    Article  PubMed  CAS  Google Scholar 

  65. Rado JT. Management treatment of negative symptoms in schizophrenia. Psychopharm Rev. 2011;46(5):33–40.

    Article  Google Scholar 

  66. Cohen E, Bernardo M, Mansana J, et al. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. J Neurol Neurosurg Psychiatry. 1999;67(1):129–30.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  67. Jandl M, Bittner R, Sack A, et al. Changes in negative symptoms and EEG in schizophrenic patients after repetitive transcranial magnetic stimulation (rTMS): an open-label pilot study. J Neural Transm. 2005;112:955–67.

    Article  PubMed  CAS  Google Scholar 

  68. Sachdev P, Loo C, Mitchell P, Malhi G. Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation. Psychiatry Clin Neurosci. 2005;59(3):354–7.

    Article  PubMed  Google Scholar 

  69. Jin Y, Potkin SG, Kemp AS, et al. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (αTMS) on the negative symptoms of schizophrenia. Schizophr Bull. 2006;32(3):556–61.

    Article  PubMed Central  PubMed  Google Scholar 

  70. Holi MM, Eronen M, Toivonev K, Toivonen P, Marttunen M, Naukkarinen H. Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophr Bull. 2004;30(2):429–34.

    Article  PubMed  Google Scholar 

  71. Hajak G, Marienhagen J, Langguth B, Werner S, Binder H, Eichhammer P. High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study. Psychol Med. 2004;34:1157–63.

    Article  PubMed  CAS  Google Scholar 

  72. Novak T, Horacek J, Mohr P, et al. The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results. Neuro Endocrinol Lett. 2006;27(1–2):209–13.

    PubMed  Google Scholar 

  73. Mogg A, Purvis R, Eranti S, et al. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophr Res. 2007;93:221–8.

    Article  PubMed  Google Scholar 

  74. Prikryl R, Kasparek T, Skotakova S, Ustohal L, Kucerova H, Ceskova E. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophr Res. 2007;95:151–7.

    Article  PubMed  Google Scholar 

  75. Goyal N, Nizamie SH, Desarkar P. Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double-blind sham-controlled study. J Neuropsychiatry Clin Neurosci. 2007;19:464–7.

    Article  PubMed  Google Scholar 

  76. Schneider AL, Schneider TL, Stark H. Repetitive transcranial magnetic stimulation (rTMS) as an augmentation treatment for the negative symptoms of schizophrenia: a 4-week randomized placebo controlled study. Brain Stimul. 2008;1:106–11.

    Article  PubMed  Google Scholar 

  77. Klein E, Kolsky Y, Puyerovsky M, Koren D, Chistyakov A, Feinsod M. Right prefrontal slow repetitive transcranial magnetic stimulation in schizophrenia: a double-blind sham-controlled pilot study. Biol Psychiatry. 1999;46:1451–4.

    Article  PubMed  CAS  Google Scholar 

  78. Fitzgerald PB, Herring S, Hoy K, et al. A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimul. 2008;1:27–32.

    Article  PubMed  Google Scholar 

  79. Levkovitz Y, Rabany L, Harel EV, Zangen A. Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study. Int J Neuropsychopharmacol. 2011;14(7):991–6.

    Article  PubMed  Google Scholar 

  80. Freitas C, Fregni F, Pascual-Leone A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr Res. 2009;108:11–24.

    Article  PubMed Central  PubMed  Google Scholar 

  81. Dlabac-de Lange JJ, Knegtering R, Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry. 2010;71(4):411–8.

    Article  PubMed  Google Scholar 

  82. Guse B, Falkai P, Wobrock T. Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm. 2010;117(1):105–22.

    Article  PubMed Central  PubMed  Google Scholar 

  83. Guse B, Falkai P, Gruber O, et al. The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls—a randomized placebo-controlled, double-blind fMRI study. Behav Brain Res. 2013;237:300–7.

    Article  PubMed  Google Scholar 

  84. Barr MS, Farzan F, Rajji TK, et al. Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial. Biol Psychiatry. 2013;73(6):510–7.

    Article  PubMed  Google Scholar 

  85. Nitsche MA, Baggio PS, Fregni F, Pascual-Leone A. Treatment of depression with transcranial direct current stimulation (tDCS): a review. Exp Neurol. 2009;219:14–9.

    Article  PubMed  Google Scholar 

  86. Brunelin J, Mondino M, Haesebaert F, et al. Efficacy and safety of bifocal tDCS as an interventional treatment for refractory schizophrenia. Brain Stimul. 2011;5(3):431–2.

    Article  PubMed  Google Scholar 

  87. Brunelin J, Mondino M, Gassab L, et al. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry. 2012;169(7):719–24.

    Article  PubMed  Google Scholar 

  88. Andrade C. Once- to twice-daily, 3 year domiciliary maintenance transcranial direct current stimulation for severe, disabling, clozapine-refractory continuous auditory hallucinations in schizophrenia. J ECT. 2013;29(3):239–42.

    Article  PubMed  Google Scholar 

  89. Coffey RJ. Deep brain stimulation devices: a brief technical history and review. Artif Organs. 2008;33(3):208–20.

    Article  PubMed  Google Scholar 

  90. Plewnia C, Schober F, Rilk A, et al. Sustained improvement of obsessive-compulsive disorder by deep brain stimulation in a woman with residual schizophrenia. Int J Neuropsychopharmacol. 2008;11:1181–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Rush University Medical Center, Chicago, IL, 60612, USA

    Jeffrey T. Rado & Edgar I. Hernandez

  2. Department of Internal Medicine, Rush University Medical Center, Chicago, IL, 60612, USA

    Jeffrey T. Rado

Authors
  1. Jeffrey T. Rado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edgar I. Hernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey T. Rado .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, Rush University, Chicago, Illinois, USA

    Philip G. Janicak

  2. UCLA Semel Institute, Los Angeles, California, USA

    Stephen R. Marder

  3. College of Medicine, University of Florida, Gainesville, Florida, USA

    Rajiv Tandon

  4. Department of Psychiatry and Behavioral Sciences, Northwestern University, Chicago, Illinois, USA

    Morris Goldman

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rado, J.T., Hernandez, E.I. (2014). Therapeutic Neuromodulation for Treatment of Schizophrenia. In: Janicak, P., Marder, S., Tandon, R., Goldman, M. (eds) Schizophrenia. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0656-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0656-7_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0655-0

  • Online ISBN: 978-1-4939-0656-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation